X1, Booth AI-17
Feb 27 - March 03
Austria Center Vienna
At this year’s European Society of Radiology (ECR), explore our suite of Breast Health Solutions for advanced cancer detection built on artificial intelligence. Discover how our solutions can best address the challenges faced by your healthcare facility, and most importantly, deliver quality care to your patients.
We will be showcasing ProFound AI™ for DBT, a high-performing, concurrent-read, cancer detection and workﬂow solution that rapidly analyzes each image accurately, detecting both malignant soft tissue densities and calcifications with unrivaled accuracy. We will also preview ProFound AI for 2D mammography* built on deep learning technology.
We are transforming breast cancer detection. Learn how at X1, booth AI-17 and experience our groundbreaking technology live on the show floor.
* CE Mark Pending, Not FDA Approved
Friday, March 1st, 18:00 CET
DO & CO Hotel Vienna
Food and cocktails will be served
Advanced RSVP required
Space is limited, register today!
Arrive by 18:00 CET for a chance to win an Apple Watch
New Frontier: Predicting Breast Cancer through Artificial Intelligence
Join your peers for an evening reception in beautiful downtown Vienna for cocktails, food and networking with leaders focused on transforming breast cancer detection.
They will share their personal experience with ProFound AI in research and clinical practice and their vision for risk assessment.
Risk stratified approach to breast cancer screening
Per Hall, MD
ProFound AI Experience: 500 consecutive screen detected abnormalities
Sylvia H. Heywang-Köbrunner, MD
Head of Reference Center Mammography Munich, Head of Brustdiagnostik Munich, Head of FFB gGmbH
Experience with Profound AI in private practice
Axel Gräwingholt, MD
Radiologie am Theater
Learn More at Clinical Presentations & Exhibits
Case Examples to Demonstrate Positive and Negative Impacts of a Deep Learning Based Concurrent Artificial Intelligence System for Digital Breast Tomosynthesis
Thursday, February 28th | 12:00 - 13:00 CET
Voice of EPOS Stage 4
Jeff Hoffmeister, MD
Vice President and Medical Director at iCAD, Inc.
How AI Can Improve Diagnostic Performance and Reduce Reading Time in Breast Tomosynthesis: Presented by iCAD, Inc.
Friday, March 1st | 13:50 CET
Artificial Intelligence Theatre
Senthil Periaswamy, PhD
Vice President of Research, iCAD Inc.
Register for a meeting or demonstration
See you in Vienna!
© 2018, iCAD Inc. All rights reserved. iCAD, the iCAD logo,, PowerLook, ProFound AI, ProFound, Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are trademarks of iCAD, Inc. Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.
X1, Booth AI-17, Feb 27 - March 03
Austria Center Vienna